Changes in angiogenesis and hypoxia-inducible factor-1α protein expression in relapsed/refractory indolent non-Hodgkin lymphomas

British Journal of Haematology

Volumn 163, Issue 5, 2013, Pages 640-645

  Minoia, Carla ^a   Quero, Carmela ^a   Asselti, Mariaconsilia ^a   Galise, Ida ^a   Marzano, Alessia L ^a   Iacobazzi, Angela ^a   Rana, Antonio ^a   Merchionne, Francesca ^a   Serratì, Simona ^a   De Tullio, Giacoma ^a   Quintana, Giovanni ^b   Casiello, Michela ^b   Maiorano, Eugenio ^c   Simone, Giovanni ^a   Zito, Francesco A ^d   Iacopino, Pasquale ^a   Guarini, Attilio ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b Division of Medical Oncology   (Italy)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^d San Paolo Hospital   (Italy)

Author keywords

Angiogenesis; Hypoxia inducible factor 1 ; Indolent non Hodgkin lymphomas; Pathogenesis; Relapse progression

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MORPHOMETRICS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; UPREGULATION;

ANGIOGENESIS; HYPOXIA-INDUCIBLE FACTOR-1Α; INDOLENT NON-HODGKIN LYMPHOMAS; PATHOGENESIS; RELAPSE/PROGRESSION;

ADULT; AGED; BIOPSY; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPH NODES; LYMPHOMA, FOLLICULAR; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RECURRENCE;

EID: 84887615505     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12560     Document Type: Article

References (13)

1. Evens, A.M., Schumacker, P.T., Helenowski, I.B., Singh, A.T., Dokic, D., Keswani, A., Kordeluk, E., Raji, A., Winter, J.N., Jovanovic, B.D., Holmgren, A., Nelson, B.P. & Gordon, L.I. (2008) Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family. British Journal of Haematology, 141, 676-680.
2. Evens, A.M., David, K.A., Helenowski, I., Nelson, B., Kaufman, D., Kircher, S.M., Gimelfarb, A., Hattersley, E., Mauro, L.A., Jovanovic, B., Chadburn, A., Stiff, P., Winter, J.N., Mehta, J., Van Besien, K., Gregory, S., Gordon, L.I., Smammo, J.M., Smith, S.E. & Smith, S.M. (2010) Hypoxia-inducible factor-1 alpha expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP. Journal of Clinical Oncology, 28, 1017-1024.
3. Federico, M., Luminari, S., Dondi, A., Tucci, A., Vitolo, U., Rigacci, L., Di Raimondo, F., Carella, A.M., Pulsoni, A., Merli, F., Arcaini, L., Angrilli, F., Stelitano, C., Gaidano, G., Dell'Olio, M., Marcheselli, L., Franco, V., Galimberti, S., Sacchi, S. & Brugiatelli, M. (2013) R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi. Journal of Clinical Oncology, 31, 1506-1513.
4. Fowler, N.H., Neelapu, S.S., Hagemeister, F.B., McLaughlin, P., Kwak, L.W. & Romaguera, J.E. (2012) Lenalidomide and Rituximab for untreated indolent lymphoma: final results of a phase II study. Blood, 120, 901.
5. Gratzinger, D., Zhao, S., Tibshirani, R.J., His, E.D., Hans, C.P., Pohlman, B., Bast, M., Avigdor, A., Schiby, G., Nagler, A., Byrne, G.E. Jr, Lossos, I.S. & Natkunam, Y. (2008) Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Laboratory Investigation, 8, 38-47.
6. Ito, K., Smith, B.R., Parashurama, N., Yoon, J.K., Song, S.Y., Miething, C., Mallick, P., Lowe, S. & Gambhir, S.S. (2012) Unexpected dissemination patterns in lymphoma progression revealed by serial imaging within a murine lymph node. Cancer Research, 72, 6111-6118.
7. Korkolopoulou, P., Thymara, I., Kavantzas, N., Vassilakopoulos, T.P., Angelopoulou, M.K., Kokoris, S.I., Dimitriadou, E.M., Siakantaris, M.P., Anargyrou, K., Panayiotidis, P., Tsenga, A., Androulaki, A., Doussis-Anagnostopoulou, I.A., Patsouris, E. & Pangalis, G.A. (2005) Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications. Leukemia, 19, 894-900.
8. Mainou-Fowler, T., Angus, B., Miller, S., Proctor, S.J., Taylor, P.R. & Wood, K.M. (2006) Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL). Leukemia & Lymphoma, 47, 223-230.
9. Molica, S., Montillo, M., Ribatti, D., Mirabelli, R., Tedeschi, A., Ricci, F., Veronese, S., Vacca, A. & Morra, E. (2007) Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia. Haematologica, 92, 1367-1374.
10. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
11. Vacca, A., Ribatti, D., Roncali, L. & Dammacco, F. (1995) Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leukemia & Lymphoma, 20, 27-38.
12. Vacca, A., Moretti, S., Ribatti, D., Pellegrino, A., Pimpinelli, N., Bianchi, B., Bonifazi, E., Ria, R., Serio, G. & Dammacco, F. (1997) Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. European Journal of Cancer, 33, 1685-1692.
13. Weidner, N., Semple, J.P., Welch, W.R. & Folkman, J. (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. The New England Journal of Medicine, 324, 1-8.